Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Oncotarget|March 10, 2016
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesisEmna Mahfoudhi, Larissa Lordier, Caroline Marty, et al.
The Journal of Experimental Medicine|July 22, 2009
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophiliaIsabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, et al.
Oncogene|March 9, 2019
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in miceKatte Rao Toppaldoddi, Maira da Costa Cacemiro, Olivier Bluteau, et al.
Research Square|November 24, 2025
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell AnemiaMarion Serra, Marine Aglave, Mohammad Salma, et al.
Blood|May 19, 2021
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopagFrancesca Basso-Valentina, Gabriel Levy, Leila N Varghese, et al.
Cells|January 11, 2022
Altered Ca<sup>2+</sup> Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal ErythropoiesisRalfs Buks, Tracy Dagher, Maria Giustina Rotordam, et al.
Nature Communications|September 28, 2020
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPNCamélia Benlabiod, Maira da Costa Cacemiro, Audrey Nédélec, et al.
American Journal of Hematology|March 19, 2026
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-Skewed Hematopoiesis in Sickle Cell AnemiaMarion Serra, Steven Akkaya, Marine Aglave, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Cell Reports|December 19, 2025
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Oncotarget|March 10, 2016
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesisEmna Mahfoudhi, Larissa Lordier, Caroline Marty, et al.
The Journal of Experimental Medicine|July 22, 2009
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophiliaIsabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, et al.
Oncogene|March 9, 2019
Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in miceKatte Rao Toppaldoddi, Maira da Costa Cacemiro, Olivier Bluteau, et al.
Research Square|November 24, 2025
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell AnemiaMarion Serra, Marine Aglave, Mohammad Salma, et al.
Blood|May 19, 2021
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopagFrancesca Basso-Valentina, Gabriel Levy, Leila N Varghese, et al.
Cells|January 11, 2022
Altered Ca<sup>2+</sup> Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal ErythropoiesisRalfs Buks, Tracy Dagher, Maria Giustina Rotordam, et al.
Nature Communications|September 28, 2020
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPNCamélia Benlabiod, Maira da Costa Cacemiro, Audrey Nédélec, et al.
American Journal of Hematology|March 19, 2026
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-Skewed Hematopoiesis in Sickle Cell AnemiaMarion Serra, Steven Akkaya, Marine Aglave, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Cell Reports|December 19, 2025
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Pageof 13